McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how ...

Consulting firm McKinsey & Company has agreed to pay $650m to resolve a United States Department of Justice investigation into the consulting firm’s work advising opioid manufacturer Purdue ...

NBC News and CNBC, citing court filings, reported Friday morning that McKinsey has agreed to pay $650 million in a five-year deferred prosecution agreement that will resolve a federal criminal ...

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis ...

WASHINGTON -- McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers ...

In the narrow 54 decision. The Supreme Court is striking down *** settlement with the makers of oxycontin providing billions to fight the opioid epidemic while protecting Purdue farmers owners from ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe ...

The United States Attorney's Office alongside other federal officials on Friday announced the resolution of criminal and civil investigations into McKinsey & Company's work with Purdue Pharma.

The United States Attorney's Office plans to announce the resolution of criminal and civil investigations into McKinsey & Company's work with Purdue Pharma on Friday. A press conference will be ...